Related Experiment Video
Updated: Dec 18, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Anti-inflammatory Withanolides from Physalis minima
Jiangping Wu1, Tao Zhang1, Meng Yu1
1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Five new withanolides from Physalis minima were identified and tested for anti-inflammatory properties. All compounds showed moderate inhibition of nitric oxide production in vitro.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Physalis minima Linn. is a plant source of bioactive compounds.
- Withanolides are a class of steroidal lactones with diverse biological activities.
- Understanding the chemical constituents and bioactivity of P. minima contributes to drug discovery.
Purpose of the Study:
- To isolate and characterize new withanolides from Physalis minima.
- To evaluate the anti-inflammatory potential of isolated compounds.
- To investigate the inhibitory effect on nitric oxide production.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation utilizing spectroscopic methods (IR, UV, HR-ESI-MS, 1D-NMR, 2D-NMR).
- In vitro anti-inflammatory assay using lipopolysaccharide-stimulated RAW 264.7 cells to measure nitric oxide production.
Main Results:
- Five new withanolides (1-5) and five known withanolides (6-10) were successfully isolated.
- The chemical structures of the new compounds were determined through comprehensive spectral analysis.
- All ten compounds exhibited moderate inhibition of nitric oxide production, with IC50 values ranging from 23.53 to 66.28 μM.
Conclusions:
- Physalis minima is a rich source of structurally diverse withanolides.
- The isolated withanolides possess anti-inflammatory properties by inhibiting nitric oxide production.
- These findings suggest potential therapeutic applications for P. minima-derived compounds.
More Related Videos
06:54Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: